Diplomat to Host First "Diplomat Dialogue" in Honor of National Cancer Survivors Day

FLINT, Mich., May 31, 2016 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today its first "Diplomat Dialogue," a video conversation slated for June 7, 2016, to take a closer look at one patient's journey. The event, hosted live from noon to 1 p.m. ET, will focus on a man named Jay and the care team who helped him along the road to wellness.

The event is the first in a series of live conversations planned between patients and health care professionals, talking about triumphs and the struggles they face. During this rare conversation, viewers will learn how Jay coped with his diagnosis and treatments, and hear his lessons from a journey with cancer.

To sign up to view the first Diplomat Dialogue, visit diplomat.is/diplomat-dialogues

"A specialty pharmacy serves the nation's most critically ill patients," said Phil Hagerman, Diplomat's CEO and chairman. "Diplomat Dialogues are a new way for us to bring patients and professionals together, listen to these stories and find insights for us all."

Viewers can participate, asking their own questions as Jay and the care team explore the patient experience and the many specialized roles involved along the way.

"These dialogues offer a rare glimpse into this world, for anyone touched by disease," said Brenda Hawkes, senior manager of patient advocacy, who will moderate the event and bring her unique perspective as a fellow cancer survivor. "We hope to offer a deeper look into what we do," she said, "and to inform and inspire others."

After the event, a recording will be posted for later viewing.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management's good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat's filings with the Securities and Exchange Commission, including "Risk Factors" in Diplomat's Annual Report on Form 10-K for the year ended December 31, 2015, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.

About Diplomat

Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients, and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.

CONTACT: 
Kali Lucas, Public Relations Coordinator 
810.768.9580 | [email protected]

Logo - http://photos.prnewswire.com/prnh/20140928/148820   

SOURCE Diplomat Pharmacy, Inc.

Related Links

http://www.diplomat.is